Institutional investors hold a majority ownership of ZTS through the 91.66% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended March 2016, these large investors purchased a net $11.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WINSLOW CAPITAL MANAGEMENT LLC Bought 6.4 Million shares of Zoetis Inc
T. ROWE PRICE ASSOCIATES, INC. Bought 4.6 Million shares of Zoetis Inc
CANTILLON CAPITAL MANAGEMENT LLC Bought 3.9 Million shares of Zoetis Inc